Digital Marketing Trends in Type 2 Diabetes
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Digital Marketing Trends in Type 2 Diabetes Report Overview
Novo Nordisk’s Ozempic.com achieved the highest total traffic across type 2 diabetes (T2D) patient brand sites in the US, with over 23 million visitors between April 2022–March 2023, followed by Eli Lilly’s Trulicity.com and AstraZeneca’s Farxiga.com. The highest proportion of traffic to branded patient T2D websites originated from direct sources, followed by organic. Novo Nordisk’s Rybelsus.com had the highest proportion of direct traffic.
The Digital Marketing Trends in the Type 2 Diabetes research report assess key digital marketing metrics of pharma assets in Type 2 Diabetes (T2D), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. The report offers metrics on website traffic volume, engagement, source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Moreover, the countries analyzed in the report are the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Key US Patient-Branded Websites | · Ozempic.com
· Trulicity.com · Farxiga.com · Jardiance.com · Mounjaro.com · Rybelsus.com · Januvia.com |
Key US HCP Branded Websites | · AstraZeneca’s Farxiga-hcp.com
· Sanofi’s Toujeopro.com · AstraZeneca’s Bydureonhcp.com · Novo Nordisk’s Ozempicpro.com |
Key EUCAN Branded Websites | · Rybelsus.ca
· Tresiba.ca · Fiasp.ca · Lilly-diabetes.de |
Enquire & Decide | Discover the perfect solution for your business needs. Enquire now and let us help you make an informed decision before making a purchase. |
Major US Patient Branded Websites for Type 2 Diabetes
The major US patient-branded websites for Type 2 Diabetes are Ozempic.com, Trulicity.com, Farxiga.com, Jardiance.com, Mounjaro.com, Rybelsus.com, and Januvia.com. Januvia.com achieved the highest average visit duration and Eli Lilly’s Mounjaro.com had the most pages per visit, while Trulicty.com had the lowest bounce rate.
Traffic Share to Branded US T2D Patient Sites, April 2022 – March 2023 (%)
For more insights into the total traffic share of the US patient-branded websites, download a free report sample
Major US HCP Branded Websites for Type 2 Diabetes
The major US HCP-branded websites for Type 2 Diabetes are AstraZeneca’s Farxiga-hcp.com, Sanofi’s Toujeopro.com, AstraZeneca’s Bydureonhcp.com, and Novo Nordisk’s Ozempicpro.com. AstraZeneca’s Farxiga-hcp.com achieved the highest total traffic across T2D HCP sites in the US, from April 2022 to March 2023, followed by Sanofi’s Toujeopro.com. Farixga-hcp.com also achieved the highest average visit duration, the highest pages per visit, and the lowest bounce rate.
Traffic Share to Branded US T2D HCP Sites, April 2022 – March 2023 (%)
For more insights into the total traffic share of the US HCP branded websites, download a free report sample
Top US Social Media Activity in Type 2 Diabetes
During April 2022–March 2023, several social media posts related to T2D were detected in the US on pharma corporate accounts, including from Novo Nordisk, Boehringer Ingelheim, and Eli Lilly. Among them, the post with the highest interaction was from Novo Nordisk’s Facebook account on Diabetes Awareness Month, promoting a video of a speaker describing how she took steps in taking care of an elderly patient with T2D.
Major EUCAN Branded Websites for Type 2 Diabetes
The major EUCAN-branded websites for Type 2 Diabetes are Rybelsus.ca, Tresiba.ca, Fiasp.ca, and Lilly-diabetes.de. Novo Nordisk’s Rybelsus.ca achieved the highest total traffic across T2D branded sites in EUCAN, from April 2022 to March 2023, followed by Novo Nordisk’s Tresiba.ca). Rybelsus.ca also achieved the highest average visit duration, while Tresiba.ca achieved the highest pages per visit and lowest bounce rate.
Traffic Share to Branded EUCAN T2D Sites, April 2022 – March 2023 (%)
For more insights into the total traffic share of the EUCAN-branded websites, download a free report sample
Top EUCAN Social Media Activity in Type 2 Diabetes
During April 2022–March 2023, several social media posts related to T2D were detected on pharma corporate accounts in EUCAN, including Novo Nordisk, Eli Lilly, AstraZeneca, and Boehringer Ingelheim. The post with the most interaction was from Novo Nordisk’s Italian Facebook account, discussing the prevention of the occurrence of cardiovascular disease in people with T2D.
Scope
This report assesses key digital marketing metrics of pharma assets in type 2 diabetes (T2D), including branded websites for patients and healthcare professionals (HCPs), unbranded websites, and social media accounts. Metrics include website traffic volume, engagement, and source, digital display advertising (DDA), paid search engine optimization (SEO), and social media post interaction. Countries include the US, 4EU (Italy, France, Germany, and Spain), the UK, and Canada (EUCAN).
Reasons to Buy
- Understand the digital marketing competitive landscape in T2D, with a view of leading patient and HCP branded assets across different regions.
- See what tactics pharma companies are using to drive traffic to their T2D branded and unbranded assets for patients and HCPs, such as DDA and paid SEO.
- Understand what sources of website traffic are generating the most visits to these assets, such as paid SEO, social media, or organic searches.
- Compare top branded assets for patients by how they address and support different patient needs.
- See what pharma social media accounts in T2D are the most active and achieving the most engagement.
Table of Contents
Frequently asked questions
-
Which is the leading US patient-branded website for Type 2 Diabetes?
Ozempic.com is the leading US patient-branded website for Type 2 Diabetes.
-
Which is the leading US HCP-branded website for Type 2 Diabetes?
Farxiga-hcp.com is the leading US HCP-branded website for Type 2 Diabetes.
-
Which is the leading EUCAN-branded website for Type 2 Diabetes?
Rybelsus.ca is the leading EUCAN-branded website for Type 2 Diabetes.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.